Free trade agreements that include intellectual property provisions have been criticized for having the potential — particularly in developing countries — to raise the prices of medicines and undermine access to them. In 1995, the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) set the standards for intellectual property protection for member states of the World Trade Organization. In 2001, the Doha